Outset Medical (OM) Cash & Equivalents (2019 - 2026)

Outset Medical (OM) has reported Cash & Equivalents for 8 consecutive years, with $151.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Cash & Equivalents rose 252.08% year-over-year to $151.0 million in Q2 2026; TTM through Jun 2026 was $151.0 million, a 252.08% increase from a year earlier, with the FY2025 full-year figure at $35.0 million, down 72.51% from the prior year.
• Cash & Equivalents was $151.0 million for Q2 2026 at Outset Medical, down from $160.5 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $252.5 million in Q1 2022 and troughed at $35.0 million in Q4 2025.
• A 5-year average of $91.9 million and a median of $67.9 million in 2022 frame the typical range for Cash & Equivalents.
• Across the five-year window, Cash & Equivalents sank 85.59% in 2023 and jumped 441.61% in 2025, its largest moves.
• Over 5 years, Cash & Equivalents stood at $76.5 million in 2022, then decreased by 6.13% to $71.8 million in 2023, then jumped by 77.26% to $127.3 million in 2024, then sank by 72.51% to $35.0 million in 2025, then surged by 331.35% to $151.0 million in 2026.
• The last three Cash & Equivalents figures came in at $151.0 million (Q2 2026), $160.5 million (Q1 2026), and $35.0 million (Q4 2025), per Business Quant data.